Drug Abuse Testing Market to See 5.6% Annual Growth Through 2023

WELLESLEY, Mass., April 23, 2019 (Newswire.com) - Improving technology and efforts to fight illicit drug use are helping to push the global drug testing market, according to the latest report by BCC Research, “Drugs of Abuse Testing: Technologies and Global Markets.”

The industry expects to see a compound annual growth rate (CAGR) of 5.6% through 2023, when it could be worth $4.6 billion, according to the report.

Major players in the market include Abbott Diagnostics, Agilent Technologies, Princeton BioMediTech and Roche Diagnostics.

Research Highlights

• Urine tests lead the market by size, with a 2018 value of $2 billion, though oral fluids lead the market by growth, with a CAGR through 2023 of 8.0%.
• North America leads the urine tests market by size, with a 2018 value of $1.4 billion. The Rest of the World regional category leads by growth, with a CAGR through 2023 of 5.8%.
• North America also leads the oral fluid testing market by size, with a 2018 value of $185.2 million, while the Rest of the World regional category again leads by growth, with a CAGR through 2023 of 8.3%.

“The overall demand for drug of abuse testing is rising,” notes the report’s authors. “DOA testing is used most heavily by healthcare service providers, public and private organizations and other government agencies. The two main technologies used for on-site screening testing and laboratory testing of drugs of abuse are immunoassay techniques and chromatography.”

Marijuana Legalization Not Expected to Slow Test Sales Through the Forecast Period

Legalized marijuana is now common in many parts of the United States as well as countries like Canada and Uruguay. Many workplaces, however, still require drug testing, and drug testing is federally mandated for millions of American workers such as commercial drivers, airline pilots, railroad engineers, and nuclear plant workers. While the legalization conflict between state and federal laws in the U.S. is likely to reach the U.S. Supreme Court, the market is unlikely to see significant change.

Editors/reporters requesting analyst interviews should contact Sarah Greenberg at [email protected].

Source: BCC Research